New treatments for hereditary angioedema (HAE) have been life-changing for people in the U.K., but more and better efforts…
Articles by Marisa Wexler, MS
Treatment with Orladeyo (berotralstat) effectively prevented swelling and improved life quality for three people with hereditary angioedema (HAE)…
Preventive treatment with Takhzyro (lanadelumab) reduced the rate of swelling attacks and improved life quality for Japanese patients with…
The U.S. Food and Drug Administration (FDA) has approved a new generic version of Firazyr (icatibant injection) for…
People with hereditary angioedema (HAE) are able to recognize early signs of swelling attacks and the need to get…
BioCryst Pharmaceuticals is teaming up with Er-Kim Pharmaceuticals to commercialize Orladeyo (berotralstat) in Turkey. Orladeyo is an oral…
A woman still doesn’t have a definitive answer as to the underlying cause of her angioedema after more than…
The U.S. Food and Drug Administration (FDA) has lifted its hold on clinical trials of deucrictibant for the on-demand…
People with hereditary angioedema (HAE) tend to experience fewer emergency room visits and hospitalizations after starting treatment with…
On-demand treatment with the experimental oral therapy PHVS416 was found to quickly and effectively ease symptoms of swelling attacks for…